Table 2.

Demographic and clinical characteristics of long-term hemodialysis patients who did or did not acquire MDRGN during the 6-mo study period

VariablePatients Who Acquired MDRGN (%; n = 11)Patients Who Did not Acquire MDRGN (%; n = 22)Unadjusted OR (95% CI)P
Age ≥66 yr5 (45)15 (68)0.300 (0.060 to 1.800)0.200
Male4 (36)7 (32)1.200 (0.300 to 4.600)0.800
White4 (36)16 (72)0.200 (0.004 to 1.200)0.070
≥3 yr on hemodialysis6 (55)10 (45)1.500 (0.300 to 7.500)0.600
Previous renal transplant0 (0)1 (5)0.500
Resident of an LTCF at baseline3 (27)3 (14)3.400 (0.300 to 36.000)0.300
Charlson score ≥46 (55)13 (59)1.500 (0.400 to 5.800)0.800
Diabetes6 (55)1 (5)10.200 (1.200 to 85.400)0.002
Nonambulatory2 (18)5 (23)0.800 (0.100 to 4.500)0.800
Draining wound at baseline4 (36)1 (505.500 (0.600 to 58.000)0.030
During follow-up period
    hospitalization ≥7 d5 (45)4 (21)3.300 (0.600 to 17.900)0.200
    antibiotic exposure ≥7 d6 (55)3 (14)5.300 (1.100 to 26.800)0.010
    developed a new wound3 (27)1 (5)6.000 (0.600 to 58.000)0.060